Triptolide targets PPP2CA/ITGA5 axis to suppress lactate-driven ovarian cancer progressionLing Ding(Renji Hospital), He Li(Renji Hospital)Chinese MedicineAugust 6, 202510.1186/s13020-025-01174-2Cited by 2SaveCiteExport RISWatch citationsRelated PapersPARP inhibitor resistance: the underlying mechanisms and clinical implications|Molecular Cancer|2020|527Resveratrol induces cell cycle arrest in human gastric cancer MGC803 cells via the PTEN-regulated PI3K/Akt signaling pathway|Oncology Reports|2015|77Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity|Cancers|2021|34